JP2013542990A5 - - Google Patents

Download PDF

Info

Publication number
JP2013542990A5
JP2013542990A5 JP2013539894A JP2013539894A JP2013542990A5 JP 2013542990 A5 JP2013542990 A5 JP 2013542990A5 JP 2013539894 A JP2013539894 A JP 2013539894A JP 2013539894 A JP2013539894 A JP 2013539894A JP 2013542990 A5 JP2013542990 A5 JP 2013542990A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
concentration
oil component
liquid oil
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2013539894A
Other languages
English (en)
Japanese (ja)
Other versions
JP2013542990A (ja
JP6111007B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2011/059861 external-priority patent/WO2012087443A1/en
Publication of JP2013542990A publication Critical patent/JP2013542990A/ja
Publication of JP2013542990A5 publication Critical patent/JP2013542990A5/ja
Application granted granted Critical
Publication of JP6111007B2 publication Critical patent/JP6111007B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2013539894A 2010-11-22 2011-11-09 局所投与用コルチコステロイド含有医薬製剤 Active JP6111007B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US45833910P 2010-11-22 2010-11-22
US61/458,339 2010-11-22
PCT/US2011/059861 WO2012087443A1 (en) 2010-11-22 2011-11-09 Pharmaceutical formulations containing corticosteroids for topical administration

Publications (3)

Publication Number Publication Date
JP2013542990A JP2013542990A (ja) 2013-11-28
JP2013542990A5 true JP2013542990A5 (https=) 2014-12-18
JP6111007B2 JP6111007B2 (ja) 2017-04-05

Family

ID=46064916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2013539894A Active JP6111007B2 (ja) 2010-11-22 2011-11-09 局所投与用コルチコステロイド含有医薬製剤

Country Status (20)

Country Link
US (3) US8809307B2 (https=)
EP (2) EP2643002B1 (https=)
JP (1) JP6111007B2 (https=)
KR (2) KR101967121B1 (https=)
CN (1) CN103228281B (https=)
AU (1) AU2011345240B2 (https=)
BR (1) BR112013012476B1 (https=)
CA (2) CA3055328C (https=)
ES (1) ES2935814T3 (https=)
HR (1) HRP20230032T1 (https=)
HU (1) HUE061270T2 (https=)
IL (1) IL226398B2 (https=)
LT (1) LT2643002T (https=)
MX (1) MX346961B (https=)
NZ (1) NZ610659A (https=)
PL (1) PL2643002T3 (https=)
PT (1) PT2643002T (https=)
RU (1) RU2568598C2 (https=)
SI (1) SI2643002T1 (https=)
WO (1) WO2012087443A1 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8809307B2 (en) * 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
CN103705441B (zh) * 2012-10-08 2017-06-23 天津金耀集团有限公司 一种丙酸倍氯米松乳膏
CN103705440B (zh) * 2012-10-08 2017-05-10 天津金耀集团有限公司 一种哈西奈德乳膏
US8962028B2 (en) * 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method
US10111956B2 (en) 2013-06-03 2018-10-30 Tolmar, Inc. Corticosteroid compositions
CN104095805B (zh) * 2014-01-02 2016-08-24 江苏知原药业有限公司 地奈德乳膏及其制备方法
US20160184431A1 (en) * 2014-03-11 2016-06-30 Promius Pharma Llc Topical compositions comprising a corticosteroid
US20190133943A1 (en) * 2015-06-18 2019-05-09 Valeant Pharmaceuticals North America Topical compositions and methods for treating skin diseases
JP6997624B2 (ja) 2015-06-18 2022-01-17 ボシュ ヘルス ユーエス,エルエルシー. 乾癬を治療するためのコルチコステロイドおよびレチノイドを含む局所用組成物
CN106474052B (zh) * 2016-12-16 2019-10-25 重庆华邦制药有限公司 二丙酸阿氯米松乳膏及其制备方法
US11311482B2 (en) 2017-05-12 2022-04-26 Bausch Health Us, Llc Topical compositions and methods for treating skin diseases
US10653656B2 (en) 2018-04-05 2020-05-19 Bausch Health Ireland Limited Topical pharmaceutical compositions for treating skin conditions
CN113453670A (zh) * 2018-09-28 2021-09-28 乔·斯图丁 类固醇和大分子的透孔递送
JP2022525221A (ja) 2019-03-14 2022-05-11 クレシタ セラピューティクス インコーポレイテッド 洗い流し組成物および活性剤を送達するためのそれらの使用
EP4103151A1 (en) * 2020-02-11 2022-12-21 Taro Pharmaceutical Industries Ltd. Compositions comprising desoximetasone and tazarotene

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU75903A1 (https=) 1976-09-29 1978-05-16
NL7105591A (en) 1971-04-24 1972-10-26 Topical antiphlogistic compsns - contng 3, 20-diketo-9 alpha, 11 beta-dichloro - 16 alpha, 17 alpha-dimethyl-21-hydroxy pregna-1,4-
DE2655570A1 (de) 1975-12-12 1977-06-16 Ciba Geigy Ag Neue polyhalogensteroide und verfahren zu ihrer herstellung
US4048310A (en) 1976-02-24 1977-09-13 E. R. Squibb & Sons, Inc. Topical steroid formulation in form of lotion or cream
US4083974A (en) 1977-03-07 1978-04-11 The Upjohn Company Topical steroidal anti-inflammatory preparations containing polyoxypropylene 15 stearyl ether
JPS5850964B2 (ja) * 1978-03-07 1983-11-14 東興薬品工業株式会社 ステロイド含有クリ−ム製剤およびその製造方法
US4299828A (en) * 1979-05-31 1981-11-10 E. R. Squibb & Sons, Inc. Corticosteroid stick formulations
US4233295A (en) 1979-05-31 1980-11-11 E. R. Squibb & Sons, Inc. Corticosteroid formulations containing sebacate carrier
AU5794680A (en) 1979-05-31 1980-12-04 E.R. Squibb & Sons, Inc. Corticosteroid stick formulations
PT73772B (en) 1980-10-06 1983-10-14 Glaxo Group Ltd Topically administrable pharmaceutical compositions containing anti-inflammatory steroids
JPS58225009A (ja) 1982-06-23 1983-12-27 Shionogi & Co Ltd コルチコステロイド外用製剤
DE3225848A1 (de) 1982-07-07 1984-01-19 Schering AG, 1000 Berlin und 4709 Bergkamen Kortikoidhaltige zubereitung zur topischen applikation
US4552872A (en) 1983-06-21 1985-11-12 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing corticosteroids
GB8401965D0 (en) 1984-01-25 1984-02-29 Beecham Group Plc Composition
JPH0764734B2 (ja) * 1986-03-17 1995-07-12 大正製薬株式会社 経皮投与製剤
CA1303991C (en) 1986-03-31 1992-06-23 Chung H. Cheng Composition and method for delivering a steroid active ingredient
JPS62238216A (ja) * 1986-04-03 1987-10-19 Otsuka Pharmaceut Factory Inc ステロイドクリ−ム製剤
US5019569A (en) 1986-11-03 1991-05-28 Ortho Pharmaceutical Corporation Reversal of glucocorticoid-induced skin atrophy
JPH0676327B2 (ja) 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイド軟膏製剤
JPH0676328B2 (ja) * 1987-04-14 1994-09-28 株式会社大塚製薬工場 ステロイドクリ−ム製剤
JPH07116026B2 (ja) 1987-07-07 1995-12-13 株式会社資生堂 ジクロフェナックナトリウム含有乳化外用剤
US5422361A (en) * 1989-12-20 1995-06-06 Schering Corporation Stable cream and lotion bases for lipophilic drug compositions
WO1991012821A1 (fr) 1990-03-02 1991-09-05 Shiseido Company, Ltd. Composition d'emulsion aqueuse contenant un analgesique anti-inflammatoire steroidien
TW218849B (https=) 1991-05-17 1994-01-11 Bristol Myers Squibb Co
US5326566A (en) 1991-05-17 1994-07-05 Bristol-Myers Squibb Company Use of dibutyl adipate and isopropyl myristate in topical and transdermal products
EP0610401A1 (en) * 1991-10-29 1994-08-17 Audio Authority Corporation Apparatus and method for interconnecting electronic products
JP4387463B2 (ja) 1997-02-20 2009-12-16 アラーガン、インコーポレイテッド タザロテンおよびコルチコステロイドによる乾癬の処置
US5972920A (en) * 1998-02-12 1999-10-26 Dermalogix Partners, Inc. Formulation containing a carrier, active ingredient, and surfactant for treating skin disorders
SE9800729L (sv) 1998-03-06 1999-09-07 Scotia Lipidteknik Ab Ny topikal formulering I
US5990100A (en) * 1998-03-24 1999-11-23 Panda Pharmaceuticals, L.L.C. Composition and method for treatment of psoriasis
GB9823036D0 (en) 1998-10-22 1998-12-16 Glaxo Group Ltd Fluticasone lotion having improved vasoconstrictor activity
AU1803100A (en) * 1999-01-06 2000-07-24 Taisho Pharmaceutical Co., Ltd. Amelometasone lotion
AU2877800A (en) 1999-02-12 2000-08-29 Susan Bershad Short contact treatment of psoriasis with topical retinoids
BR9917389B1 (pt) 1999-06-25 2013-04-24 formulaÇÕes tàpicas compreendendo agentes de penetraÇço na pele e o uso das mesmas.
US6479058B1 (en) 1999-09-02 2002-11-12 Mccadden Michael E. Composition for the topical treatment of poison ivy and other forms of contact dermatitis
US6656928B1 (en) * 1999-09-02 2003-12-02 Mccadden Michael E. Composition for the topical treatment of rashes, dermatoses and lesions
US6387383B1 (en) 2000-08-03 2002-05-14 Dow Pharmaceutical Sciences Topical low-viscosity gel composition
US6579512B2 (en) * 2001-06-15 2003-06-17 Crutchfield, Iii Charles E. Topical steroid spray
US6709663B2 (en) 2001-08-31 2004-03-23 Healthpoint, Ltd. Multivesicular emulsion drug delivery systems
JP4299142B2 (ja) * 2001-12-21 2009-07-22 ローディア インコーポレイティド 陽イオン界面活性剤と陰イオン界面活性剤を含む安定な組成物
US6765001B2 (en) 2001-12-21 2004-07-20 Medicis Pharmaceutical Corporation Compositions and methods for enhancing corticosteroid delivery
US7544674B2 (en) 2002-10-25 2009-06-09 Galderma S.A. Topical skin care composition
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US20060018937A1 (en) 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
JP2004359585A (ja) 2003-06-03 2004-12-24 Medorekkusu:Kk 被膜形成型の副腎皮質ステロイド薬含有外用製剤
US20050101582A1 (en) 2003-11-12 2005-05-12 Allergan, Inc. Compositions and methods for treating a posterior segment of an eye
US8741333B2 (en) 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8449867B2 (en) * 2004-08-31 2013-05-28 Stiefel Research Australia Pty Ltd Microemulsion and sub-micron emulsion process and compositions
JPWO2006098353A1 (ja) 2005-03-15 2008-08-28 協和醗酵工業株式会社 外用剤
KR20080047312A (ko) 2005-04-25 2008-05-28 다우 파마슈티컬 사이언시즈 건선 치료를 위한 클로베타솔 분무 제형의 용도
CA2632616A1 (en) 2005-12-09 2007-06-21 Nycomed Us Inc. Topical glucocorticosteroid formulations
CA2633464A1 (en) 2005-12-14 2007-09-07 Zars Pharma, Inc. Compositions and methods for dermal delivery of drugs
WO2008038147A2 (en) 2006-07-05 2008-04-03 Foamix Ltd. Foamable vehicle comprising dicarboxylic acid or dicarboxylic acid ester and pharmaceutical compositions thereof
EP2097065A2 (en) 2006-11-29 2009-09-09 Foamix Ltd. Foamable waterless compositions with modulating agents
US20100323998A1 (en) * 2007-08-06 2010-12-23 Glenmark Pharmaceuticals Ltd. Topical composition containing the combination of mupirocin and beclomethasone
RU2470645C2 (ru) 2007-09-10 2012-12-27 Гленмарк Фармасьютикалс Лимитед Фармацевтическая композиция для местного применения, содержащая комбинацию фузидовой кислоты и кортикостероида
WO2009084020A2 (en) 2007-10-18 2009-07-09 Glenmark Pharmaceuticals Limited Topical composition comprising halobetasol and salicylic acid
KR101848095B1 (ko) 2008-06-26 2018-04-11 안테리오스, 인코퍼레이티드 경피 운반
EP2343978A4 (en) * 2008-10-03 2013-11-27 Nexmed Holdings Inc STABILIZED COMPOSITION FOR TREATING PSORIASIS
US20100249060A1 (en) * 2009-02-23 2010-09-30 Smith Jan G Topical formulation of low level clobetasol propionate for treating disorders of the skin and mucous membranes
PT2400951T (pt) 2009-02-25 2018-11-26 Mayne Pharma Llc Composições de espuma tópica
US20130310355A1 (en) 2009-12-15 2013-11-21 Young Pharmaceuticals, Inc. Low toxicity topical active agent delivery system
WO2012051614A2 (en) 2010-10-15 2012-04-19 Kulesza John E Delivery of hydrophobic bioactive agents
US8809307B2 (en) 2010-11-22 2014-08-19 Dow Pharmaceutical Sciences, Inc. Pharmaceutical formulations containing corticosteroids for topical administration
US11957753B2 (en) 2010-11-22 2024-04-16 Bausch Health Ireland Limited Pharmaceutical formulations containing corticosteroids for topical administration
US8962028B2 (en) 2012-10-18 2015-02-24 MiCal Pharmaceuticals LLC—H Series, a Series of MiCal Pharmaceuticals LLC, a Multi-Division Limited Liability Company Topical steroid composition and method

Similar Documents

Publication Publication Date Title
JP2013542990A5 (https=)
RU2013128607A (ru) Фармацевтические составы, содержащие кортикостероиды, для топикального применения
JP2012532889A5 (https=)
JP5111117B2 (ja) ステロイドの経時的安定性が改善された外用製剤
JP2010280689A (ja) 副腎皮質ステロイド送達を増進するための組成物および方法
JP2945993B2 (ja) 外用剤
US11839656B2 (en) Pharmaceutical formulations containing corticosteroids for topical administration
JP2016520656A5 (https=)
JP2004519451A5 (https=)
BRPI0403316A (pt) Formulações de solução farmacêutica em aerossol adequadas para inalação oral ou nasal contendo glucocorticóides estáveis ao armazenamento; método para formulações estabilizantes e uso de um estabilizador
RU2003119439A (ru) Фармацевтическая композиция для лечения фимоза с помощью местного кортикостериода
US6300326B1 (en) Composition and method for control and treatment of cutaneous inflammation
Floden et al. Comparison of the response of psoriasis, over a 6-month period, to clobetasol propionate and fluocinolone acetonide ointments
RU2025132660A (ru) Лечение псориаза
RU2010154665A (ru) Способ предотвращения использования кортикостероидов
FALK Fluocinolone acetonide in propylene glycol
WO2016198998A1 (en) A medicinal cream made using clobetasol propionate and incorporating a biopolymer and a process to make it
JP2949236B2 (ja) 外用剤
Engen Drug Class Literature Scan: Topical Steroids